检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:赖冰妮 廖础欣[1] 郑绮姗[1] 刘锐锋[1] LAI Bingni;LIAO Chuxin;ZHENG Qishan;LIU Ruifeng(Department of Drug Information,Zhongshan City People's Hospital,Zhongshan Guangdong 528400,China)
机构地区:[1]中山市人民医院药品信息科,广东中山528400
出 处:《中国卫生标准管理》2024年第10期150-153,共4页China Health Standard Management
摘 要:克林霉素是林可霉素衍生物,也是临床常用的抗生素类型,可通过抑制敏感菌株蛋白质合成,发挥抗感染效果。克林霉素的抗菌活性较强,但是不良反应较多,需要进一步提升其临床用药合理性,保障患者临床治疗有效性和安全性。当前,针对克林霉素临床应用的处方点评管理规范逐渐完善,处方点评工作有序开展,但是仍需进一步明确该类抗生素使用中存在的问题,进而制定相应的干预对策,以保证克林霉素临床应用的安全性和有效性。为此,文章对综合性医院门诊克林霉素使用情况专项处方点评情况进行了现状分析,并总结了克林霉素处方点评中发现的问题,针对问题汇总了提升克林霉素用药合理性的相关建议。Clindamycin is a derivative of lincomycin and a commonly used type of antibiotic in clinical practice.It can exert anti infective effects by inhibiting protein synthesis in sensitive strains.Clindamycin has strong antibacterial activity,but there are many adverse reactions.It is necessary to further improve its clinical medication rationality to ensure the effectiveness and safety of clinical treatment for patients.At present,the prescription review management standards for the clinical application of clindamycin are gradually improving,and the prescription review work is being carried out in an orderly manner.However,it is still necessary to further clarify the problems in the use of this type of antibiotic,and develop corresponding intervention strategies to ensure the safety and effectiveness of clindamycin clinical application.Therefore,this article analyzes the current situation of special prescription reviews on the use of clindamycin in outpatient clinics of comprehensive hospitals,summarizes the problems found in the review of clindamycin prescriptions,and summarizes relevant suggestions for improving the rationality of clindamycin medication.
关 键 词:综合性医院 门诊 克林霉素 使用情况 专项处方点评 合理用药
分 类 号:R917[医药卫生—药物分析学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.170